Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.47 |
| ▸ | TUBB | P07437 | 1/20 | 0.47 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.47 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.47 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.47 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.47 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.47 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.47 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.47 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.47 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.47 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.47 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.47 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.47 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3804774 | 0.97 | ALOX15 (0.54) | ALOX15TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL3732928 | 0.91 | ALOX15 (0.49) | ALOX15TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL3001850 | 0.85 | CASP3 (0.47) | ALOX15CASP3CHEK1KCNH2ADORA2A | |
| SCHEMBL2998632 | 0.84 | ALOX15 (0.46) | ALOX15TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL31022169 | 0.84 | ALDH1A1 (0.43) | ALOX15MAPTLMNACHEK1KCNH2 | |
| SCHEMBL31022328 | 0.81 | RIPK1 (0.50) | MAPTMEN1KMT2ARAB9ALMNA | |
| SCHEMBL27808394 | 0.80 | CHEK1 (0.38) | ALOX15CASP3CHEK1KCNH2ADORA2A | |
| SCHEMBL3005238 | 0.79 | NPY5R (0.45) | MEN1KMT2ARAB9ALMNASMN1; SMN2 | |
| SCHEMBL3420158 | 0.79 | NPC1 (0.39) | ALOX15TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL27808310 | 0.78 | CHEK1 (0.40) | ALOX15TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213583-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-07-03 | — | — | US | claimed |
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-03-13 | — | — | US | claimed |
| EP-4470541-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MitoImmune Therapeutics Inc. (KR) | 2024-12-04 | — | — | EP | claimed |
| US-20240374646-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | MITOIMMUNE THERAPEUTICS INC. (KR) | 2024-11-14 | — | — | US | claimed |
| WO-2024191106-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF EPILEPSY | 주식회사 미토이뮨테라퓨틱스 | 2024-09-19 | — | — | WO | claimed |
| CN-118647383-A | Anti-ovarian aging pharmaceutical composition and application thereof | 水疗免疫疗法有限公司 | 2024-09-13 | — | — | CN | claimed |
| US-20240269145-A1 | USE OF INDOLE COMPOUND AS INHIBITORS OF FERROPTOSIS | MITOIMMUNE THERAPEUTICS INC. (KR) | 2024-08-15 | — | — | US | claimed |
| EP-4382106-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | MitoImmune Therapeutics Inc. (KR) | 2024-06-12 | — | — | EP | claimed |
| WO-2023182840-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE THEREOF | 주식회사 미토이뮨테라퓨틱스 | 2023-09-28 | — | — | WO | claimed |
| WO-2023146341-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | 주식회사 미토이뮨테라퓨틱스 | 2023-08-03 | — | — | WO | claimed |
| US-20150038500-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISORDERS | CATHOLIC UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-02-05 | — | — | US | claimed |
| EP-2230238-B1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG LIFE SCIENCES LTD (KR) | 2013-12-11 | — | — | EP | claimed |
| US-8436038-B2 | Indole and indazole compounds as an inhibitor of cellular necrosis | LG LIFE SCIENCES LTD. (KR) | 2013-05-07 | — | — | US | claimed |
| US-8349885-B2 | Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect | LG LIFE SCIENCES LTD. (KR) | 2013-01-08 | — | — | US | claimed |
| US-20120270203-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG CHEM, LTD. (KR) | 2012-10-25 | — | — | US | claimed |
| US-20100291533-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG LIFE SCIENCES LTD. (KR) | 2010-11-18 | — | — | US | claimed |
| EP-2230238-A2 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG Life Sciences Ltd. (KR) | 2010-09-22 | — | — | EP | claimed |
| US-20100197673-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD (KR) | 2010-08-05 | — | — | US | claimed |
| EP-2178870-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG Life Sciences Ltd. (KR) | 2010-04-28 | — | — | EP | claimed |
| WO-2009025478-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD. (KR) | 2009-02-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374646-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | TFAM, FIS1, AIFM1 | ALOX15 217/4885TUBB4A 1975/4885TUBB 1436/4885 |
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | CYP19A1, NR5A1, CYP11A1 | ALOX15 187/4885TUBB4A 3467/4885TUBB 3500/4885 |
| US-20250213583-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE THEREOF | ZC3HAV1, ZC3HAV1L, SARS1 | ALOX15 1500/4885TUBB4A 3959/4885TUBB 4130/4885 |
| US-20120270203-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | IDO1, IDO2, INMT | ALOX15 264/4885TUBB4A 1692/4885TUBB 662/4885 |
| US-20100197673-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | IDO1, IDO2, NFATC1 | ALOX15 181/4885TUBB4A 2756/4885TUBB 1746/4885 |
| US-20150038500-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISORDERS | AQP1, EYA3, SF1 | ALOX15 669/4885TUBB4A 4547/4885TUBB 4233/4885 |
| US-20100291533-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | IDO1, IDO2, INMT | ALOX15 264/4885TUBB4A 1692/4885TUBB 662/4885 |
| US-20240269145-A1 | USE OF INDOLE COMPOUND AS INHIBITORS OF FERROPTOSIS | AIFM2, FECH, SLC40A1 | ALOX15 30/4885TUBB4A 4646/4885TUBB 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.